Iron plays a central role in the body’s ability to produce energy, transport oxygen, and maintain healthy red blood cells. For people with diabetes, the relationship with iron is especially complex. Both iron deficiency and iron overload can disrupt energy levels, worsen insulin resistance, and increase the risk of complications such as anemia. Understanding how iron influences these pathways is essential for optimizing diabetes management and overall well-being.

The Role of Iron in Energy Metabolism and Oxygen Transport

Biochemical Functions of Iron

Iron is a critical component of hemoglobin, the protein inside red blood cells that binds oxygen and delivers it to tissues. Without adequate iron, hemoglobin production drops, reducing the blood’s oxygen-carrying capacity. Beyond red blood cells, iron is also incorporated into myoglobin, which stores oxygen in muscle tissue, and into numerous enzymes involved in cellular respiration. Cytochromes, for example, rely on iron to transfer electrons in the mitochondria where ATP (the body’s energy currency) is generated. When iron levels fall short, every energy-demanding process — from physical activity to cognitive function — is impaired.

How Iron Deficiency Leads to Fatigue

Fatigue is the hallmark symptom of iron deficiency, even before anemia develops. Without enough iron, the mitochondria cannot produce ATP efficiently. Muscles receive less oxygen, and metabolic byproducts accumulate, leading to early exhaustion. In people with diabetes, fatigue can compound the challenges of daily glucose monitoring, medication adherence, and physical activity, making it harder to maintain glycemic control.

Anemia Prevalence in Diabetic Populations

Anemia is two to three times more common in people with diabetes than in the general population. The prevalence increases with longer disease duration, poorer glycemic control, and the presence of complications such as diabetic kidney disease. Studies report that 20 to 30 percent of patients with type 2 diabetes have some degree of anemia, often going undiagnosed because symptoms are mistakenly attributed to diabetes itself.

Causes of Anemia in Diabetes

Several factors contribute to the high rate of anemia in diabetes. Chronic inflammation, a hallmark of insulin resistance, increases the production of hepcidin — a liver‑derived hormone that blocks iron absorption from the diet and traps iron inside storage cells. This leads to a functional iron deficiency even when total body iron is adequate, a condition called anemia of chronic disease. Additionally, diabetic nephropathy reduces erythropoietin production, the hormone that stimulates red blood cell formation, further aggravating anemia. Certain medications, including metformin (which can cause B12 deficiency) and ACE inhibitors (which may lower hemoglobin), also play a role.

Symptoms of Anemia in Diabetes

Common symptoms include fatigue, weakness, pallor, shortness of breath on exertion, dizziness, and difficulty concentrating. In people with diabetes, these symptoms can easily be mistaken for high or low blood sugar, depression, or the general burden of a chronic illness. As a result, anemia is often underrecognized. Untreated anemia can worsen diabetic complications by increasing the heart’s workload, reducing tissue oxygenation, and contributing to peripheral neuropathy.

Iron Deficiency vs. Iron Overload in Diabetes

Iron Deficiency

Iron deficiency is the most common cause of anemia worldwide, and people with diabetes face unique risks for developing it. In addition to inflammation-driven hepcidin blockade, dietary inadequacy, malabsorption, and blood loss (from diabetic ulcers, gastrointestinal bleeding, or heavy menstruation) can deplete iron stores. When deficiency progresses, red blood cells become microcytic (small) and hypochromic (pale), and hemoglobin levels drop. Correction of iron deficiency typically improves energy, exercise tolerance, and quality of life.

Iron Overload and Insulin Resistance

Excess iron, on the other hand, is increasingly recognized as a contributor to insulin resistance and beta‑cell dysfunction. Iron is a pro-oxidant; when present in surplus, it catalyzes the formation of reactive oxygen species that damage mitochondria, interfere with insulin signaling, and promote inflammation. Hereditary hemochromatosis — a genetic disorder that causes iron accumulation — is associated with a high incidence of diabetes, often referred to as “bronze diabetes.” Even mild iron overload, common in postmenopausal women and men who supplement unnecessarily, can worsen glycemic control. Reducing iron stores through phlebotomy has been shown to improve insulin sensitivity in some studies.

The Dual Burden: Both Deficiency and Excess Are Problematic

This dual nature makes iron management in diabetes a balancing act. Neither too little nor too much is healthy. The goal is to maintain iron levels within the optimal range to support energy metabolism without promoting oxidative stress. Because chronic inflammation can elevate ferritin (a marker of iron stores) even when functional iron is low, interpreting iron tests in diabetic patients requires care. A comprehensive iron panel is essential before any intervention.

Causes of Iron Deficiency in People with Diabetes

Chronic Inflammation and Hepcidin

As noted, elevated hepcidin from systemic inflammation reduces dietary iron absorption and traps iron in macrophages and liver cells. This is the primary driver of iron deficiency in type 2 diabetes. Even with adequate dietary iron, the body cannot mobilize it for red blood cell production. This form of iron deficiency is often resistant to oral supplementation unless the underlying inflammation is addressed.

Dietary Factors

Many people with diabetes are encouraged to adopt heart‑healthy eating patterns such as the Mediterranean or DASH diet, which can be lower in heme iron (from red meat). Vegetarian or vegan diets, while beneficial for overall health, contain only non‑heme iron, which is less bioavailable. Without careful planning — including pairing iron-rich plant foods with vitamin C sources and avoiding tea or coffee at meals — iron deficiency can develop gradually.

Gastrointestinal Issues

Diabetes can affect the entire gastrointestinal tract. Gastroparesis, which delays gastric emptying, can reduce appetite and lead to poor nutrient intake. Celiac disease, an autoimmune condition associated with type 1 diabetes, causes villous atrophy that impairs iron absorption in the duodenum. Additionally, chronic use of proton pump inhibitors (often prescribed for reflux) reduces stomach acid needed to convert dietary iron into an absorbable form.

Blood Loss

Blood loss is a direct cause of iron depletion. In diabetes, sources include diabetic foot ulcers that ooze blood, gastrointestinal bleeding from angiodysplasia or NSAID use, and, in women, heavy menstrual bleeding. Diabetic nephropathy can also cause microscopic blood loss in the urine. Because the body loses iron primarily through blood, even small but chronic losses can deplete stores over time.

Impact of Iron Levels on Diabetes Management

Energy Levels and Physical Activity

Physical activity is a cornerstone of diabetes management, but iron deficiency makes regular exercise feel overwhelming. Low iron reduces the oxygen supply to working muscles, increases perceived effort, and prolongs recovery. Patients may become sedentary, which worsens insulin sensitivity and glycemic control. Correcting iron deficiency can restore exercise tolerance and improve long‑term outcomes.

Insulin Resistance and Oxidative Stress

Excess iron leads to oxidative damage in the pancreas and peripheral tissues, impairing insulin secretion and promoting insulin resistance. The reactive oxygen species generated by iron can damage beta cells and reduce the expression of glucose transporter proteins. Clinical studies have shown that higher serum ferritin levels predict a greater risk of developing type 2 diabetes. For those already diagnosed, elevated ferritin is associated with higher hemoglobin A1c and more difficulty achieving targets.

Glycemic Control and Complications

Both iron deficiency anemia and iron overload can influence A1c readings. In iron deficiency, red blood cell turnover is reduced, leading to falsely elevated A1c values due to longer hemoglobin exposure to glucose. Conversely, iron overload can suppress erythropoiesis, also affecting A1c accuracy. Clinicians should be aware of these artifacts when interpreting lab results. Furthermore, anemia compounds the risks of diabetic retinopathy and nephropathy by increasing tissue hypoxia and oxidative stress.

Monitoring Iron Status in Diabetic Patients

Key Tests

To assess iron status accurately, a panel comprising serum ferritin, serum iron, total iron‑binding capacity (TIBC), and transferrin saturation is standard. Hemoglobin and mean corpuscular volume (MCV) indicate anemia and red blood cell size. In diabetic patients with inflammation, serum ferritin can be misleadingly elevated because it is an acute‑phase reactant. In that situation, a low transferrin saturation (below 20%) despite a normal or high ferritin suggests functional iron deficiency. Soluble transferrin receptor is an alternative marker that is less affected by inflammation.

Interpretation in Context

No single test is sufficient. A high ferritin with low transferrin saturation points to anemia of chronic disease. A low ferritin (below 30 ng/mL) confirms true iron deficiency. Iron overload is indicated by elevated ferritin (above 200–300 ng/mL in women, 300–400 in men) together with high transferrin saturation (above 50%). Because ferritin can rise with inflammation, a value in the upper normal range should be interpreted cautiously in diabetic patients with obesity or active infection.

Frequency of Testing

Routine screening for iron deficiency is not recommended for all diabetic patients, but it is warranted in those with unexplained fatigue, anemia, chronic kidney disease, dietary restrictions, or gastrointestinal symptoms. Annual testing with a complete blood count and iron panel is reasonable for patients with stage 3 or higher chronic kidney disease. Repeat testing after treatment helps confirm normalization of stores.

Managing Iron Levels: Diet and Supplements

Dietary Iron Sources

Iron in food exists as heme iron (found in meat, poultry, and fish) and non‑heme iron (found in plants and fortified foods). Heme iron is absorbed more efficiently (25–30%) than non‑heme iron (1–10%) and is not significantly inhibited by dietary factors. For individuals who eat meat, lean sources such as beef, pork, liver, and poultry can boost iron stores. For those on plant‑based diets, emphasis should be on lentils, beans, tofu, spinach, fortified cereals, and pumpkin seeds. Pairing these with vitamin C (e.g., citrus fruits, bell peppers, tomatoes) enhances non‑heme absorption, while avoiding tea, coffee, and calcium‑rich foods at the same meal helps prevent inhibition.

Iron Supplementation

When diet alone is insufficient, oral iron supplements are the first line for iron deficiency. Ferrous sulfate (325 mg providing 65 mg elemental iron) is the most common form, but ferrous gluconate and ferrous fumarate are also effective. The typical dose for deficiency is 150–200 mg of elemental iron per day, taken on an empty stomach with vitamin C. Side effects including constipation, nausea, and dark stools can be minimized by starting with a lower dose or taking with a small amount of food. Iron supplements should never be taken without confirmed deficiency because of the risk of overload, especially in men and postmenopausal women who have no physiological iron losses.

Managing Inflammation and Hepcidin

In anemia of chronic disease, iron supplementation alone is often ineffective. Treatment should focus on controlling the underlying inflammation through improved glycemic control, weight loss, and anti‑inflammatory medications if appropriate. In severe cases, intravenous iron or erythropoiesis‑stimulating agents may be needed, particularly in patients with chronic kidney disease. These require specialist oversight.

Special Populations

Type 1 Diabetes and Celiac Disease

People with type 1 diabetes have a higher prevalence of autoimmune conditions, including celiac disease, which directly impairs iron absorption. Routine screening for celiac disease is recommended in type 1 diabetes, and iron deficiency in this group should prompt evaluation. Additionally, type 1 diabetes often develops in younger individuals who may have increased iron needs from growth and menstruation.

Type 2 Diabetes and Obesity

Obesity‑related inflammation raises hepcidin and promotes functional iron deficiency. However, obesity also increases total iron stores in some individuals due to higher dietary intake and chronic low‑grade inflammation that elevates ferritin. Weight loss and bariatric surgery can improve iron status, but surgery itself can lead to deficiency if absorption is reduced. Post‑surgery patients require lifelong iron monitoring.

Diabetic Kidney Disease

Anemia in diabetic nephropathy is multifactorial: erythropoietin deficiency, iron deficiency (both absolute and functional), and hepcidin elevation are common. Management often requires a combination of iron supplementation (oral or intravenous) and erythropoiesis‑stimulating agents. The goal is to achieve a hemoglobin of 10–11 g/dL; higher targets have been associated with cardiovascular harm. Nephrologists typically direct this care.

Pregnancy and Diabetes

Pregnancy increases iron requirements substantially due to fetal development and expanded blood volume. Women with pregestational or gestational diabetes need careful iron monitoring. Iron deficiency anemia in pregnancy is linked to poor maternal and fetal outcomes, but excess iron may worsen insulin resistance. Routine supplementation in all pregnant women is common, but doses should be individualized based on baseline ferritin.

Practical Steps for Patients and Providers

Recognize Symptoms

Patients should be educated to report persistent fatigue, shortness of breath, cold hands and feet, brittle nails, and unusual cravings for ice or dirt (pica) to their healthcare team. Clinicians should consider iron deficiency in any diabetic patient with fatigue that does not resolve with improved glucose control.

Request an Iron Panel When Indicated

Rather than checking only hemoglobin, a full iron panel (serum iron, ferritin, TIBC, transferrin saturation) provides a complete picture. In the setting of inflammation, adding soluble transferrin receptor can help differentiate true deficiency from anemia of chronic disease.

Tailor Dietary Advice

Dietitians can help patients design meal plans that optimize iron intake without conflicting with diabetes dietary goals. Emphasizing iron‑rich lean meats, fish, legumes, and dark leafy greens, while timing consumption away from inhibitors, is practical. For iron overload, dietary adjustments to reduce high‑iron foods and avoid vitamin C supplements at meals can help.

Coordinate Care

Primary care providers, endocrinologists, nephrologists, and dietitians should collaborate on iron management. Patients with persistent deficiency or suspected overload should be referred for further evaluation, including testing for hereditary hemochromatosis (HFE gene mutation) or gastrointestinal causes of blood loss.

Conclusion

Iron is far more than a single nutrient — it is a pivotal player in energy metabolism, oxygen delivery, and the intricate hormonal and inflammatory pathways that define diabetes. Both iron deficiency and iron overload pose significant risks for people with diabetes, influencing fatigue, insulin resistance, glycemic control, and long‑term complications. Regular monitoring with appropriate tests, individualized dietary strategies, and cautious use of supplements are essential to maintain iron balance. By actively managing iron status, patients and providers can improve energy levels, support diabetes self‑care, and enhance overall quality of life. For the latest evidence and clinical guidelines, consult resources such as the NIH Office of Dietary Supplements, the American Diabetes Association, and the CDC’s chronic kidney disease information.